Our aim is to fulfil the wish lists of the medical teams on all of the wards we support. Funds are directly injected into the ward so that every penny spent is used where it is needed most.
Our funding has enabled the total refurbishment of the Treatment Suite of the Chartwell Cancer & Leukaemia Unit, The Princess Royal Hospital (PRUH), Farnborough.
Other achievements include the procurement of a “Virtual Conferencing” facility, a state-of-the-art Breast Ultrasound Scanner, computers, specialist wheelchairs, equipment for the community nursing teams and supplies for the doctors, nurses and patients specifically for the ward – amongst so many other enhancements.
In 2016, we were also instrumental in succeeding to overturn the management decision to permanently close the inpatients unit which protected a vitally important service in the community.
In February 2022, The Chartwell Cancer Trust fulfilled its commitment by raising £750,00 for a new and modernised Oncology Unit, within the dedicated new Rainbow children’s unit at Croydon University Hospital. This is the charity’s biggest achievement, a fantastic milestone making a lasting difference and legacy to the experiences of young people living with cancer.
We are extremely proud to be able to provide this support to oncology staff, patients and families in every way possible.
“We are truly grateful to the Chartwell Cancer Trust for its contribution to the holistic care of our cancer patients over the years. It is thanks to the continuous, imaginative, and generous support from the Chartwell Cancer Trust that we have been able to address unmet needs of our patients and their families during their long and challenging journeys from cancer diagnosis throughout treatment and even beyond remission.”
Dr Vicky Gkreka, Consultant Haematologist, Lead Clinician (Haematology), the Princess Royal University Hospital
“The Chartwell Cancer Trust has been instrumental in setting up our new research lab and Cell Culture facility enabling us to carry out experimental procedures at the very core of our research activities. It has given us the right environment, people and resources to deliver pioneering research, which has the potential to improve the lives and outcomes of millions of people.“
Professor John Strouboulis, Chair in Molecular Erythropoiesis, School of Cancer & Pharmaceutical Science